{"id":135322,"date":"2022-02-07T14:23:09","date_gmt":"2022-02-07T22:23:09","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2022\/02\/keren-haruvi-president-sandoz-us-head-of-north-america-global-generic-medicine-access-for-all"},"modified":"2022-02-07T14:23:09","modified_gmt":"2022-02-07T22:23:09","slug":"keren-haruvi-president-sandoz-us-head-of-north-america-global-generic-medicine-access-for-all","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2022\/02\/keren-haruvi-president-sandoz-us-head-of-north-america-global-generic-medicine-access-for-all","title":{"rendered":"Keren Haruvi \u2014 President, Sandoz US, Head Of North America \u2014 Global Generic Medicine Access For All"},"content":{"rendered":"<p><\/p>\n<p><iframe style=\"display: block; margin: 0 auto; width: 100%; aspect-ratio: 4\/3; object-fit: contain;\" src=\"https:\/\/www.youtube.com\/embed\/BKQoxkZBm3k?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; encrypted-media; gyroscope;\n   picture-in-picture\" allowfullscreen><\/iframe><\/p>\n<p>Pioneering global generic medicine access to improve and extend people\u2019s lives \u2014 keren haruvi snir-president, sandoz US, head of north america.<\/p>\n<hr>\n<p>Keren Haruvi is President of Sandoz US and Head of their North America business (<a href=\"https:\/\/www.novartis.us\/about-us\/our-leadership\/us-country-leadership\/keren-haruvi).\">https:\/\/www.novartis.us\/about-us\/our-leadership\/us-country-l\u2026n-haruvi).<\/a><\/p>\n<p>Sandoz is a division of the Novartis Group and a global leader in generic pharmaceuticals and biosimilars and was established in 2003, when Novartis united all of its generics businesses under the name Sandoz \u2013 a single global brand with a long history. Since then, Sandoz has grown into a leading global generics business with annual sales of approximately US$10 billion.<\/p>\n<p>In her current role, Keren leads Sandoz\u2019 largest commercial and country organization \u2013 the United States \u2013 which is responsible for over 35% of Sandoz global revenue. She also oversees Sandoz commercial operations in Canada. In addition to serving on the Novartis Country Leadership Team, Keren is a member of the Global Sandoz Executive Committee.<\/p>\n<p>Prior to joining Sandoz, Keren served as Global Head of M&amp;A at Novartis International AG. Her early career began at Teva Pharmaceutical Industries where she steadily advanced in leadership roles to Senior VP, Global Business Development and Alliance Management.<\/p>\n<div class=\"more-link-wrapper\"> <a class=\"more-link\" href=\"https:\/\/lifeboat.com\/blog\/2022\/02\/keren-haruvi-president-sandoz-us-head-of-north-america-global-generic-medicine-access-for-all\">Continue reading \u201cKeren Haruvi \u2014 President, Sandoz US, Head Of North America \u2014 Global Generic Medicine Access For All\u201d | &gt;<\/a><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pioneering global generic medicine access to improve and extend people\u2019s lives \u2014 keren haruvi snir-president, sandoz US, head of north america. Keren Haruvi is President of Sandoz US and Head of their North America business (https:\/\/www.novartis.us\/about-us\/our-leadership\/us-country-l\u2026n-haruvi). Sandoz is a division of the Novartis Group and a global leader in generic pharmaceuticals and biosimilars and was [\u2026]<\/p>\n","protected":false},"author":400,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,43,19,39,45],"tags":[],"class_list":["post-135322","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-business","category-chemistry","category-economics","category-finance"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/135322","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/400"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=135322"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/135322\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=135322"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=135322"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=135322"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}